Rating History for Cubist Pharmaceuticals (CBST) by Goldman Sachs

More Stocks Rated by Goldman Sachs | Latest Ratings for CBST
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/31/2013 N/A Downgrade Neutral
(Conviction Buy)		 59.00
(N/A)		 57.00
(101.94)		 78.84% Details